ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

INN Innovision Res.

34.75
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Innovision Res. LSE:INN London Ordinary Share GB0030308448 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 34.75 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Interim Results

05/12/2003 7:00am

UK Regulatory


RNS Number:8971S
Innovision Research&Technology PLC
05 December 2003



                      INNOVISION RESEARCH & TECHNOLOGY PLC
            Interim Results for the 6 months ended 30 September 2003


Innovision Research and Technology, the electronics technology solutions
provider, announces its results for the 6 months ended 30 September 2003.


                                  Highlights

Financial

*   Turnover increased to #1.02 million (2002: #214k)

*   Loss reduced to #735k (2002: #1.77 million)

*   Earnings per share of (1.86)p (2002: (4.47)p)

*   Continued tight cash control with #3.9 million cash at the half year end


Operational

*   Contactless low-cost transport ticket due to be launched in February 2004

*   Other opportunities now moving into important final phases of development

*   Achieving Quality Standard ISO 9001 and the Medical Standard ISO13485 will 
    open up new commercial opportunities



Commenting on the results, Barton Clarke, CBE, Chairman said:

"We continue to make good progress and 2004 is a pivotal year for a number of
projects. The planned commercialisation of key products with market leading
customers will drive sales growth and profitability.

As mass RFID adoption finally gets underway we have a strong position at the
heart of the industry, good long-term revenue potential and a solid sales
pipeline that should enable us to continue to take advantage of the many
opportunities arising."


                                                                 5 December 2003


Enquiries:

Innovision Research & Technology plc                   Tel: 0118 936 6311
Mike Wroe, Finance Director

College Hill                                           Tel: 020 7457 2020
Matthew Smallwood




Chairman's Statement

Turnover in the 6 months ended 30th September 2003 was #1.02m (2002: #214k),
this improvement reflects the continued focus of working with market leading
customers on high quality funded development work with medium-term royalty
potential.

This sales growth, achieved with a lower cost base, has resulted in a
substantial reduction in the loss for the period to #735k (2002: #1,767k).
Careful cost and cash management has ensured that at the period end the company
had cash available of #3.9m (March 2003: #4.5m). This means that with a number
of key opportunities now moving into the final phases of development, we are
able to increase investment to ensure that the necessary people, systems and
processes are in place to maximise the future revenue potential of the business.
Examples of this are our recent quality accreditations for ISO 9001 and the
medical standard, ISO 13485, both of which will open up new commercial
opportunities with major customers.

As previously announced, one focus of the Company's Radio Frequency
Identification (RFID) Research and Development programme has been the design of
a low-cost, contactless mass-transit ticket.  This product is now nearing
completion and is due to be launched in February 2004 at UITP, one of the
world's premier transport shows.  As one of only two low-cost products scheduled
to be included in the UK transport standards, and with early adopters identified
in the United States, we are in a strong position in a market with huge
potential. The number of ticket converters, in addition to our existing
licensee, expressing an interest in licensing this technology further reinforces
our confidence in this market.

Elsewhere, we continue to make good progress, both in the medical sector where
we are driving RFID standards and on a number of exciting consumer market
projects.  In particular, one RFID chip design has just entered pilot production
and will be field-tested by a major European customer during 2004.  We are
already working on further projects for this customer and look forward to
providing more details of this significant opportunity. Two other projects, both
in the consumer sector are now moving towards their final development phases
with production decisions expected during 2004.

Although Wal-Mart's decision to introduce RFID tagging from 2005 has no direct
impact on the Company, the market as a whole is now developing rapidly and in
the specific market sectors in which we operate we are seeing increased interest
and activity. Challenges still remain however we expect a number of key project
milestones to be met over the coming year, have a strong position at the heart
of this growing industry, good long-term revenue potential and a solid sales
pipeline all of which should enable us to continue to take advantage of the many
opportunities arising.  I am pleased with our development in 2003 and look
forward to further progress in 2004.


Barton Clarke CBE
5 December 2003



INDEPENDENT REVIEW REPORT TO INNOVISION RESEARCH & TECHNOLOGY PLC

Introduction

We have been instructed by the company to review the financial information set
out on pages 4 to 8 and we have  read the other information contained in the
interim report and considered whether it contains any apparent misstatements  or
material inconsistencies with the financial information.

This report, including the conclusion, has been prepared for and only for the
company for the purpose of their interim report and for no other purpose. We do
not, therefore in producing this report, accept or assume responsibility for any
other purpose or to any other person to whom this report is shown or into whose
hands it may come save where expressly agreed by our prior consent in writing.

Directors' responsibilities

The interim report, including the financial information contained therein, is
the responsibility of, and has been approved by the directors. It is best
practice that the accounting policies and presentation applied to the interim
figures should be consistent with those applied in preparing the preceding
annual accounts except where any changes, and the reasons for them, are
disclosed.

Review work performed

We conducted our review in accordance with guidance contained in Bulletin 1999/4
issued by the Auditing Practices Board as if that Bulletin applied. A review
consists principally of making enquiries of management and applying analytical
procedures to the financial information and underlying financial data and based
thereon, assessing whether the accounting policies and presentation have been
consistently applied unless otherwise disclosed. A review excludes audit
procedures such as tests of controls and verification of assets, liabilities and
transactions. It is substantially less in scope than an audit performed in
accordance with Auditing Standards and therefore provides a lower level of
assurance than an audit. Accordingly we do not express an audit opinion on the
financial information.

Review conclusion

On the basis of our review we are not aware of any material modifications that
should be made to the financial information as presented for the six months
ended 30 September 2003.


BAKER TILLY
Chartered Accountants
2 Bloomsbury Street
London WC1B 3ST

5 December 2003




PROFIT AND LOSS ACCOUNT
For the six months ended 30 September 2003
                                                                Notes      6 months      6 months    12 months
                                                                           ended 30      ended 30     ended 31
                                                                          September     September        March
                                                                               2003          2002         2003
                                                                        (unaudited)   (unaudited)    (audited)
                                                                              #'000         #'000        #'000

TURNOVER                                                            2         1,020           214          802

Cost of sales                                                                 (153)          (82)        (169)

Gross Profit                                                                    867           132          633

Administrative expenses
       Normal operating                                                     (1,740)       (2,099)      (4,023)
       Exceptional items                                                          -             -        (423)


OPERATING LOSS                                                                (873)       (1,967)      (3,813)

Interest receivable                                                              76           140          244

LOSS ON ORDINARY ACTIVITIES BEFORE TAXATION                                   (797)       (1,827)      (3,569)

Taxation                                                            3            62            60          120

LOSS ON ORDINARY ACTIVITIES AFTER TAXATION                                    (735)       (1,767)      (3,449)



LOSS PER SHARE                                                            Pence per     Pence per    Pence per
                                                                              share         share        share

Basic and diluted                                                   4        (1.86)        (4.47)       (8.72)




The operating loss for the period arises from the company's continuing
operations.

No separate Statement of Total Recognised Gains and Losses has been presented as
all such gains and losses have been dealt with in the Profit and Loss Account.





BALANCE SHEET
30 September 2003
                                                            Notes      As at 30      As at 30        As at
                                                                      September     September     31 March
                                                                           2003          2002         2003
                                                                    (unaudited)   (unaudited)    (audited)
                                                                          #'000         #'000        #'000             
                                                                                                    
FIXED ASSETS
Tangible assets                                                             279           499          331
Investments                                                                  14            14           14

                                                                            293           513          345
CURRENT ASSETS
Debtors                                                                     809           578          780
Cash at bank and in hand                                        5         3,948         6,040        4,532

                                                                          4,757         6,618        5,312

CREDITORS: Amounts falling due within one year                            (608)         (272)        (480)

NET CURRENT ASSETS                                                        4,149         6,346        4,832

NET ASSETS                                                                4,442         6,859        5,177

CAPITAL AND RESERVES
Called up share capital                                                     395           395          395
Share premium                                                             9,834         9,834        9,834
Profit and loss account                                                 (5,787)       (3,370)      (5,052)

SHAREHOLDERS' FUNDS                                                       4,442         6,859        5,177






CASHFLOW STATEMENT
For the six months ended 30 September 2003
                                                                        6 months      6 months     12 months
                                                                        ended 30      ended 30      ended 31
                                                                       September     September         March
                                                                            2003          2002          2003
                                                                     (unaudited)   (unaudited)     (audited)
                                                                           #'000         #'000         #'000

Operating loss                                                             (873)       (1,967)       (3,813)
Depreciation                                                                  71            94           284
(Profit) / loss on sale of fixed assets                                      (9)           (3)             1
(Increase) / decrease in debtors                                           (106)           396           214
Increase / (decrease) in creditors                                           128          (97)           110

Net cash outflow from operating activities                                 (789)       (1,577)       (3,204)

Returns on investments and servicing of finance
                Interest received                                             94           288           390

Taxation                                                                     122           112           155

Capital expenditure and financial investment
                Purchase of tangible fixed assets                           (41)          (88)         (131)
                Sale of tangible fixed assets                                 30             9            26

Net cash flow for capital expenditure and financial                         (11)          (79)         (105)
investment

Cash outflow before use of liquid resources and                            (584)       (1,256)       (2,764)
financing

Management of liquid resources
                Decrease  in treasury deposit account                        846         1,272         2,580

Increase / (decrease) in cash in period                                      262            16         (184)


Reconciliation of net cash flow to movement in net funds

Increase / (decrease) in cash in period                                      262            16         (184)
Cash outflow from decrease in liquid resources                             (846)       (1,272)       (2,580)

Change in net funds resulting from cash flow                               (584)       (1,256)       (2,764)

Opening net funds                                                          4,532         7,296         7,296

Closing net funds                                                          3,948         6,040         4,532





NOTES TO THE INTERIM FINANCIAL STATEMENTS
For the six months ended 30 September 2003


1    BASIS OF PREPARATION
     
     The financial information contained in this interim report does not 
     constitute statutory accounts within the meaning of section 240 Companies 
     Act 1985. The interim results, which have been reviewed but not audited, 
     have been prepared using accounting policies consistent with those used in 
     the preparation of the Annual Report and Accounts for the year ended 31 
     March 2003. Those accounts have been filed with the Registrar of Companies 
     and received an unqualified audit report which did not contain a statement 
     under section 237(2) or (3) Companies Act 1985.


2    TURNOVER

     The company's turnover was all derived from its principal activity and was 
     made to the following geographical markets:

                                                                    6 months      6 months     12 months
                                                                    ended 30      ended 30      ended 31
                                                                   September     September         March
                                                                        2003          2002          2003
                                                                 (unaudited)   (unaudited)     (audited)
                                                                       #'000         #'000         #'000

     United States of America                                            127            61           127
     United Kingdom                                                      148            31           297
     Rest of Europe                                                      745           102           347
     Rest of the World                                                     -            20            31
                                                                     _______       _______       _______
                                                                       1,020           214           802

     Sales by business activity were as follows:
     Development engineering                                             956           133           552
     Licence fees and technology sales                                    23            51           116
     Royalties                                                            41            30           134

                                                                       1,020           214           802

3    TAXATION

     Taxation for the six months to 30 September 2003 is based on the estimated 
     tax credits for Research & Development.


4    LOSS PER SHARE

     Basic loss per share has been calculated by dividing the loss for the 
     period of #735,101 (2002:#1,767,293 ) by the weighted average number of 
     shares in issue during the period. During the period the weighted average 
     number of shares in issue was 39,554,390 (2002: 39,554,390). 

     There is no dilution as a result of outstanding options.


5    FINANCIAL INSTRUMENTS

     The company's financial instruments comprise cash balances as follows:
                                             
                                                                      6 months      6 months    12 months
                                                                      ended 30      ended 30     ended 31
                                                                     September     September        March
                                                                          2003          2002         2003
                                                                   (unaudited)   (unaudited)    (audited)
                                                                         #'000         #'000        #'000

     Sterling money market deposit                                       3,697         5,851        4,543
     Current accounts                                                      251           189         (11)

                                                                         3,948         6,040        4,532


     The company holds small balances in foreign currencies to meet current 
     trading requirements. Cash  surplus to immediate requirements is held on 
     money market deposits.

     The company's income is received principally in US Dollars and Euros.  
     Where practical in respect of timings and certainty of amounts, the company 
     considers the use of forward exchange facilities to hedge individual 
     foreign currency transactions.  Included in debtors due within one period 
     is #16,379 (2002 : #63,844) relating to balances designated in US Dollars 
     and #235,394 designated in Euros (2002 : #18,604).  Similarly, creditors 
     due within one period include #20,475 (2002: #5,351 ) relating to balances 
     designated in US Dollars.



6    The interim financial statements set out on pages 2 to 8 were approved by 
     the directors on 4 December 2003.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

IR ILFLDFRLSIIV

1 Year Innovision Research&technology Chart

1 Year Innovision Research&technology Chart

1 Month Innovision Research&technology Chart

1 Month Innovision Research&technology Chart

Your Recent History

Delayed Upgrade Clock